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Edited by Gerrit van MeerAbstract The purpose of this study was to investigate whether,
after oxidative injury in vivo, liver mitochondrial phospholipids
suﬀered from structural defects similar to those we have
previously observed after either chemical oxidation or respiration
state IV incubation of isolated mitochondria in vitro. Oxidative
injury of the liver was simulated by endogastric administration of
CCl4 to rats in variable amounts for diﬀerent times, under
various conditions. Measurements of the phospholipid bilayer
packing order were carried out by electron paramagnetic
resonance (EPR) spectrometry of oriented planar samples of
phospholipids extracted from liver mitochondria, spin labeled
with 5-doxylstearoyl-lecithin. Disordering of the bilayer was
revealed by the anisotropy loss of EPR spectra and reached a
maximum value 4.5 h after CCl4 administration, vanishing
thereafter. The observed disorder also increased with the amount
of CCl4 administered, showing distinct dose-dependence, while
administration of resveratrol soon after carbon tetrachloride
decreased bilayer disordering by 50%. On the contrary, the order
parameter S of spin labeled lecithin in isolated mitochondrial
membranes from intoxicated rats revealed no change in mem-
brane ﬂuidity after oxidative stress. It is concluded that the
phospholipid damage leading to disturbed bilayer geometry after
oxidative attack already observed in model membranes and in
isolated mitochondria in vitro also occurs in a simulated
pathological state in vivo, indicating its possible occurrence also
in real oxidative stress-linked pathologies as a contribution to the
onset/sustaining of related diseases.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Spectral anisotropy1. Introduction
Oxidative attack on membranes by reactive oxygen species
(ROS) and/or reactive nitrogen species (RNS) is considered
responsible for or a supporter of various pathological states
[1–3]. In many cases, oxidation of phospholipid polyunsat-* Corresponding author. Fax: +39-80-5443317.
E-mail address: f.m.megli@biologia.uniba.it (F.M. Megli).
Abbreviations: ROS, reactive oxygen species; RNS, reactive nitrogen
species; n-DSPC, b-n-doxylstearoyl-lecithin; EPR, electron paramag-
netic resonance; SPB, supported phospholipid bilayers
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duction and formation of conjugated dienes, is thought to
bring about indirect functional damage through alterations
of the normal lipid environs of integral proteins [4,5]. Re-
cently, we were able to demonstrate that oxidation of
phospholipids leads to alterations of the lipid bilayer con-
sisting mainly in the loss of packing order of phospholipid
molecules, visible as the anisotropy loss of electron para-
magnetic resonance (EPR) spectra of spin labeled oriented
planar layers, possibly as an early stage of a process leading
to membrane breakdown. This eﬀect was independent of the
oxidizing system, as it was observed both in various lecithin
types oxidized by the Fenton reagent [6] and in phospho-
lipids of isolated mitochondria incubated under respiration
state IV in vitro [7].
In this paper, we extend our EPR study of the bilayer
packing order in oriented layers to liver mitochondrial phos-
pholipids from a living intoxicated animal model, that is rats
subjected to endogastric administration of carbon tetrachlo-
ride, under various conditions. The CCl4-treated rat is a
widespread animal model for hepato-pathology relying on the
renowned intoxicating power of CCl4 [8], acting as a radical
initiator through its prime hepatic metabolite CCl3 [9,10]. As a
consequence, the chemical is capable of raising oxidative stress
in the short term and hepatic cirrhosis upon prolonged treat-
ment. We made use of it to ﬁnd preliminary support for the
idea that phospholipid bilayer disorders ﬂank ROS-linked
pathologies, and that peroxidized phospholipids at least in part
could be considered as the molecular basis of some oxidative
stress-induced diseases.
The packing order of oriented planar samples of mito-
chondrial phospholipids extracted from CCl4-treated rat liver
was monitored by measuring the anisotropy loss of the EPR
spectra of spin labeled planar oriented samples as described
[6]. We have shown that after administration of CCl4,
phospholipid bilayer disorder increases with treatment time
until a maximum value, fading thereafter following a steady
state proﬁle, and that the observed disorder is dose-depen-
dent. As observed in the case of isolated mitochondria, the
renowned antioxidant resveratrol is able to counteract the
eﬀect of CCl4 treatment, especially when administered si-
multaneously with carbon tetrachloride. On the contrary,
membrane ﬂuidity of intoxicated mitochondria, as measured
in spin labeled membranes by the EPR order parameter S,
proved to be unaﬀected, as it was in isolated mitochondria in
vitro [7].ation of European Biochemical Societies.
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Fig. 1. Low-ﬁeld band of the perpendicular EPR spectrum of a dis-
ordered SPB sample. Dashed line, ﬁrst derivative; solid line, second
derivative. Measurement is shown of the height of the parallel (h00k) and
perpendicular (h00?) component second derivative positive lobe, useful
for calculation of the R00 parameter.
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2.1. Materials
Spin labeled lecithin was obtained by acylation of egg yolk lyso-
lecithin (Sigma) with either 5- or 12- or 16-doxylstearic acid (Sigma)
according to Boss et al. [11]. Resveratrol, 3,40,5-trihydroxy-trans-stil-
bene, was also from Sigma.
2.2. Treatment of animals
Wistar albino rats weighting 180–220 g after fasting overnight were
anaesthetized with diethyl ether. CCl4 (in mineral oil 1:1 by vol.) was
administered in the ratio of 4 g per kg body weight via gavage, and the
animals were killed by decapitation after 1–24 h time intervals. Al-
ternatively, CCl4 was administered in 2–8 g (steps of 2 g) per kg and
sacriﬁce followed after 4.5 h. In another set of experiments, 15 mg
resveratrol (about 75 mg per kg body weight) suspended in 0.8 ml
maize oil was administered to rats immediately after CCl4 or after a 2 h
time lag. 3–4 animals were used for each experimental datum.
2.3. Phospholipid preparation
Rat liver was taken soon after sacriﬁce and homogenized in a Pot-
ter–Evelhjem homogenizer in 250 mM sucrose and 1 mM Tris–HCl,
pH 7.4. Mitochondria were prepared according to standard techniques
in the same buﬀer and, after assaying protein content according to
Bradford [12], lipids were extracted by the method of Bligh and Dyer
[13]. Phospholipid phosphorus was assayed by the Nakamura method
[14] and the presence of conjugated dienes was conﬁrmed by reading
phospholipid samples re-dissolved in cyclohexane at 235 nm as de-
scribed [15].
2.4. Spin labeling of mitochondria
Spin labeled SUVs were prepared by sonication (Branson Soniﬁer
W-250 D operated at 40 W output for 15 min at intervals, in an ice
bath) of an EYPC/b-n-doxylstearoyl-lecithin (n-DSPC) 2:1 by mol
mixture in 125 mM KCl, 25 mM HEPES, and 2.5 mM MgCl2. After
centrifuging (10 min 10 000 rpm, ALC PK121R centrifuge), the SUV
suspension was concentrated to 5 mM in an Amicon ultra-ﬁlter. 5 mg
of freshly prepared mitochondrial membranes was incubated with 0.1
ml SUV for 20 min at 37 C. At the end, the incubation vessel was
refrigerated in ice and 0.5 ml of 0.43 M sucrose was layered at its
bottom. Spin labeled mitochondria were pelleted by centrifugation at
10 000 rpm for 10 min [16] and re-suspended immediately in 50 ll SUV
buﬀer for EPR spectrometry and membrane ﬂuidity measurement.
2.5. Measurement of EPR spectral anisotropy
50 ll ethanol solution of spin labeled phospholipids was deposited
on a thin narrow glass slide and taken to dryness under vacuum (1–2
mbar, 37 C). 5–10 ll distilled water was layered onto the bottom of a
ﬂat quartz tissue cell well and the slide was placed into the well with its
rear side adhering to the water layer. After covering the well, the
phospholipid layer was allowed to hydrate as judged by the trans-
parency of the sample [7].
The cell was inserted into the cavity of a 9-GHz Varian E-9 Century
Line EPR spectrometer at room temperature and oriented so that the
normal (coincident with the fatty acid chain direction) to its plane was
either perpendicular or parallel to the magnetic ﬁeld direction. Out-
coming spectra were accordingly labeled either ? or k, respectively.
Instrumental settings were: 338/335 mT (perpendicular/parallel) ﬁeld
set with 12 mT scan width, 100 kHz and 0.2 mT modulation frequency
and amplitude. Radiating ﬁeld power and frequency were 20 mW and
9.4/9.5 GHz (perpendicular/parallel), respectively.
2.6. Membrane ﬂuidity gradient determination
EPR spectra were scanned as above on 25 ll samples in glass cap-
illaries at room temperature with ﬁeld set and radiating ﬁeld shifted to
339 mT and 9.35 GHz, respectively.
In both cases, the spectra were digitized by means of an EPR-Data
System from STELAR (Mede, Italy) coupled to the spectrometer,
using interactive software written by Stan Sykora.
2.7. Spectral analysis
In hydrated oriented planar phospholipid bilayers on solid support,
phospholipid molecules orient perpendicularly to the supporting glass
slide so that the fatty acid chains’ z-axis is normal to its plane as is thez-axis of a nitroxide ring bound to the fatty acid chain of a spin labeled
phospholipid. Molecular tumbling of a nitroxide ring placed at a rigid
chain position such as C-5 is strongly reduced, resulting in the mo-
lecular frame rigidly oriented along x-, y- and z-axes directions, with
the spin label’s z-axis marking the sample’s z-axis orientation. Under
these conditions, the sample behaves as an ordered crystal and yields
two well-separated EPR spectra: one dominated by gk and Ak tensors,
only visible when the nitroxide z-axis (coaxial with both the fatty chain
long axis and the glass slide normal) is parallel to the applied magnetic
ﬁeld, and the other dominated by g? and A? tensors, appearing only
when the glass slide normal is perpendicular to the applied magnetic
ﬁeld [17,18]. Therefore, the two spectra are not simultaneously visible
and the perpendicular switches to the parallel one upon rotating the
sample, showing angular dependence. As a consequence, angular de-
pendence of EPR spectra of planar phospholipid bilayers reveals
molecular order. Conversely, in this situation, the appearance of par-
allel EPR spectrum bands in the perpendicular spectrum and vice versa
reveals fatty acid chain tilt and is displayed as loss of angular depen-
dence which in turn becomes a telltale sign of packing disorder.
The extent of disorder can be estimated by the height of the parallel
spectrum bands appearing in the perpendicular EPR spectrum. The
better-resolved parallel spectrum low-ﬁeld band of the perpendicular
spectrum is the most convenient marker of disorder (Fig. 1, dashed
line). EPR bands are best resolved in the second derivative presenta-
tion of spectra, as reported in Fig. 1 (solid line) [7]. In order to com-
pare diﬀerent disorder degrees, we devised an empirical disorder index
R00 calculated as the ratio of the parallel spectrum low ﬁeld band sec-
ond derivative height to the height of the second derivative of the
perpendicular spectrum low ﬁeld band, as follows:
R00 ¼ h00k=h00?
with the quantities h00k and h
00
? measured as illustrated in Fig. 1.
The mitochondrial membrane ﬂuidity gradient was determined in
normal and intoxicated rat liver mitochondria spin labeled with either
5-, 12- or 16-DSPC by measuring the order parameter S from the
diﬀerent spin labels EPR spectra, as follows [19,20]:
S ¼ ðAk  A?Þ=½Azz  1
2
ðAxx þ AyyÞ3. Results and discussion
Membrane oxidative attack after CCl4 treatment of rats is a
well established phenomenon widely used as a model for oxi-
dative stress in vivo [8–10]. The molecule is quickly metabo-
lized in the liver to the radical species CCl3 [21], and oxidative
attack on membrane components follows, with lipoperoxida-
tion initiated by extraction of a bisallylic hydrogen atom from
polyunsaturated fatty acids, as would happen with ROS.
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Fig. 2. EPR spectra of SPB samples consisting of liver mitochondrial
phospholipids from variously treated rats. Gavage: (A) mineral oil
(blank), 4.5 h treatment; (B) 1 ml 1:1 CCl4/mineral oil, 4.5 h; (C) 1 ml
1:1 CCl4/mineral oil, 24 h ; and (D) 2 ml 1:1 CCl4/mineral oil, 4.5 h.
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phospholipid bilayer after oxidative attack by ROS on mito-
chondrial phospholipids in isolated mitochondria in vitro un-
der respiration state IV conditions [7]. By use of chemically
oxidized phospholipids, we were also able to establish that
lipoperoxidation readily appears as increasingly isotropic EPR
spectra of supported planar phospholipid bilayers which in
turn become disorderly packed and destabilized to the point of
membrane breakdown [8]. We adopted the CCl4-treated rat
model in order to ascertain whether peroxidized phospholipids
forming in vivo in a manner similar to lipoperoxidation oc-
curring in some oxidative stress-linked diseases were able to
alter the phospholipid bilayer structure in the same way as we
previously observed in the above-cited simpler models.
After preliminary conﬁrmation of lipoperoxidation in mi-
tochondria from intoxicated rat liver by detection of conju-
gated dienes in phospholipid extracts, spin labeled supported
phospholipid bilayers (SPB) samples of those phospholipids
were scanned by EPR spectrometry. When lipoperoxidation
was present, EPR spectra of SPB samples of mitochondrial
phospholipids invariantly yielded disordered spectra, as shown
by the anisotropy loss apparent in Fig. 2B (4.5 h/0.5 ml CCl4)
and 2 D (4.5 h/1 ml CCl4). Here, parallel spectrum bands show
prominently in the perpendicular spectra and vice versa in
comparison with spectra in Fig. 2A (4.5 h/0.5 ml mineral oil,
blank), which appear completely free of parallel/perpendicular
cross contamination. R00 values of 0.48 and 0.68, respectively,
were calculated from the derivative of those spectra, while the
blank R00 value ranged around 0.20. Based on our previous
studies [6,7], the observed behavior of EPR spectral anisotropy
can be attributed to CCl4 oxidative attack on phospholipids in
vivo.
The trend of bilayer disordering with CCl4 treatment time
is reported in Fig. 3 as the variation of the disorder index
R00 with time. R00 values were calculated from the derivative
of EPR spectra reported in Fig. 2A–C and more, as illus-
trated in Fig. 1. From Fig. 3 it can be seen that bilayer
disordering reaches its maximum extent 4.5 h after CCl4
treatment of the animals as indicated by an R00 value of 0.47.
Thereafter, and as expected in a living model, mechanisms
for the removal of intoxication succeeded in abolishing the
eﬀect, and phospholipids extracted 24 h after CCl4 gavage
look completely ‘‘repaired’’ judging by the disordering eﬀect
vanishing with time (see also Fig. 2C). The solid line was
obtained by means of the equations used to describe the
steady state approximation [22], and ﬁts data points with
v2 ¼ 0:187, corresponding to P < 0:05%. This observation
might indicate the existence of two competing phenomena:
(1) the onset of oxidative stress producing oxidized phos-
pholipids (hence bilayer disordering) and (2) detoxication
[10] that is removal of oxidized phospholipids and progres-
sive return to a normal phospholipid pattern with an or-
dered bilayer.
The dependence of bilayer disordering upon CCl4 gavage
dose was also analyzed and the results are shown in Fig. 4.
This ﬁgure reports the increase of R00 value as measured from
the derivative of spectra similar to that reported in Fig. 2D (1
ml CCl4, 4.5 h, bold line), with increasing CCl4 dose after 4.5 h
treatment time. Disordering of phospholipid bilayers appears
almost linearly linked to the gavage dose, further conﬁrming
the dependence of the observed eﬀect on carbon tetrachloride
oxidative stress of membranes in vivo.To further prove this dependence and to gain conﬁrmation
that oxidative attack in vivo is responsible for the observed
eﬀects as we found in model systems, the counteracting eﬀect
of antioxidant resveratrol was also studied in vivo via gavage
to CCl4-treated animals. Results are reported in Fig. 5, from
which it can be seen that EPR spectra of SPBs made of liver
mitochondrial phospholipids from rats treated with CCl4 and
resveratrol (Fig. 5C, R00 ¼ 0:29) reveal a much more ordered
phospholipid bilayer structure than the one yielding the spec-
trum in panel B (R00 ¼ 0:59), from rats treated with CCl4 alone,
in comparison with the blank (mineral oil/maize oil) spectrum
(Fig. 5A, R00 ¼ 0:19). The anisotropy recovery of spectra in
panel C over spectra in panel B is clearly attributable to the
antioxidant properties of resveratrol. Nonetheless, the eﬀect of
resveratrol was dependent on the time-lag after CCl4 treat-
ment. In fact, judging from R00 value, EPR spectra of
phospholipid SPBs from rats treated with resveratrol 2 h after
CCl4 gavage showed spectral anisotropy recovery about half as
24201612840
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Fig. 3. Proﬁle of anisotropy loss, expressed as R00 value, in spin labeled
mitochondrial phospholipid SPBs with CCl4 treatment time of rats.
Each experimental point is the means of three measures of phospho-
lipid extracts from liver mitochondria of three animals. Vertical bars
represent S.D.
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Fig. 5. EPR spectra of liver mitochondrial phospholipid SPBs from
rats after (A) placebo, (B) 0.75 ml CCl4, (C) 0.75 ml CCl4 plus 15 mg
resveratrol gavage. Animals were killed 4.5 h after treatment.
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latter case an R00 value of 0.29 was calculated against R00 ¼ 0:43
measured in case of 2 h time lag in resveratrol administration.
These values are reported in Fig. 6 as the percentage of the R00
value obtained without resveratrol rating 0.59, taken as 100%
disorder.
The data presented so far conﬁrm that oxidative attack on
membrane phospholipids in vivo also results in the phospho-
lipid bilayer disordering, and that disorder is readily revealed
by the anisotropy loss of EPR spectra of supported planar
bilayers of extracted phospholipids. The observed disordering
appears to be proportional to the oxidant amount and oxi-
dation time and to respond to antioxidant treatment. The key
to this proportionality lies in our previous observations
showing that disordering of the bilayers has a molecular basis,
since it is proportional to the amount of oxidized phospholipid
molecules. This in turn enriches the order index R00 with
quantitative valence.10,80,60,40,20
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Fig. 4. Trend of anisotropy loss in EPR spectra of liver mitochondrial
phospholipid SPBs from rats treated with increasing amounts of CCl4
for 4.5 h. Anisotropy loss is expressed in terms of the disorder index R00
(see Section 2) calculated from EPR spectra similar to the one in Fig.
2D, bold line. Each data point is the means of four to six measure-
ments on phospholipid extracts from three to four animals. S.D.s are
given as vertical bars.On the contrary, the order parameter S, whose value reﬂects
membrane ﬂuidity, again proved a poor indicator of lipoper-
oxidation also in the case of in vivo oxidative stress. In fact,
mitochondria from rats treated with 0.75 ml CCl4 and spin
labeled with either 5- or 12- or 16-DSPC yielded EPR spectraNone 0 h lag 2 h lag 
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Fig. 6. The residual disorder of EPR spectra of SPBs made with liver
mitochondrial phospholipids after diﬀerent treatments of rats is ex-
pressed as the percent ratio of R00 of samples obtained in the presence
of resveratrol to R00 value obtained with CCl4 alone (100% disorder).
Rats were treated with 0.75 ml CCl4 in 1:1 mixture with mineral oil and
with 15 mg resveratrol in maize oil after the indicated time lag. Data
are the means of 4–6 SPBs measurements of lipid extracts from 3 to 4
animals. Vertical bars represent the S.D. of measurements.
Table 1
Order parameter S of n-DSPC in isolated mitochondria
C(n) 5 12 16
Blanka 0.645 0.006 0.313 0.005 0.118 0.008
CCl4
b 0.639 0.007 0.309 0.009 0.122 0.006
Liver mitochondria from rats treated with either amineral oil or b0.75
ml CCl4 in 0.75 ml mineral oil were spin labeled as described under
Section 2. The S value was calculated from EPR spectra as also de-
scribed therein. Figures are the means of three experiments and the
S.D. is indicated.
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zero diﬀerence with respect to the values calculated in the case
of placebo-treated rats, as reported in Table 1. Although
membrane ﬂuidity variation has been tentatively linked to
ROS formation and aging, the present results further conﬁrm
our previous observations of scarce sensitivity of membrane
ﬂuidity to lipoperoxidation. This link is controversial [23,24]
and in some cases membrane ﬂuidity modulation appears to be
linked more to cholesterol content variations with aging than
to lipoxidation [25,26]. Our present and previous results ﬁrmly
demonstrate that acyl chain packing order appears much more
aﬀected than mobility, and that the order index R00 should be
considered a much more reliable reporter of the bilayer status
than the order parameter S when lipoxidation is involved.
In the light of our previous results, the present data conﬁrm
that oxidative damage to membrane phospholipids by what-
ever method is reﬂected in structural defects of the phospho-
lipid bilayer. These structural defects consist mainly in
disorder of the phospholipid packing leading to destabilization
of the membrane structure and possibly to membrane break-
down. The fact that the same structural defects as those ob-
served in simpler models occur after oxidative stress in a living
pathological model suggests that lipoperoxidation, occurring
in many other cases such as aging [27,28], hyper-caloric diet
[29], inﬂammation [30,31] and some diseases [1–3] as revealed
by the presence of malondialdehyde, can always aﬀect the
phospholipid bilayer structure of natural membranes leading
also in these cases to membrane disordering. In turn, a ruined
phospholipid bilayer no longer provides the proper environ-
ment for optimal integral enzymes functioning [5]. From this
point of view, oxidized phospholipids and related bilayer dis-
ordering can be viewed as the molecular basis for sustaining
and spreading some oxidative stress-linked diseases. Further-
more, destabilization of the bilayer might also favor ROS
penetration in the inner bilayer and into membrane compart-
ments, promoting overspreading of the oxidative attack to
other membrane components and to whole organs.References
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